News archive

Read the latest news from the nanomedicine world.

Five health industry associations – COCIR, EFPIA, EuropaBio, MedTech Europe & Vaccines Europes – are currently in discussions towards the creation of a Public-Private Partnership under Horizon Europe, the next EU Framework Programme for Research & Innovation. As part of the creation of the partnership, all relevant stakeholders and the public are invited to contribute to the development of the Strategic Research Agenda.

You will find the draft SRIA and a short presentation of the Health PPP on

Bring your contribution to shape the Health PPP!

Today is launched a public consultation on the Strategic Research Agenda (SRA) for the European Partnership for Health Innovation (accessible here).

DEADLINE to answer the survey: November, 24, 2019.

Why a European Partnership for Health Innovation?

Healthcare in Europe is at a crossroads. It faces increasing challenges on a number of fronts; at the same time, technological and scientific advances offer new opportunities to solve these challenges. Bridging the gap to address today’s health and translational challenges will require a multi-sector Public-Private Partnership.European Partnership on Health Innovation PPP NOBEL ETPN EFPIA COCIR Europa Bio MedTech Europe Vaccines

ETPN & NOBEL fully support the Health PPP.

The ETPN and the NOBEL Project fully support this unique opportunity to make a global medical revolution happen in Europe. For the first time, a real synergy between Pharma, Biotech and Medtech in Europe will help designing new solutions to improve the quality of life of millions of patients, while ensuring sustainable healthcare systems. Indeed we will answer the consultation.

Share the news, get involved in Health PPP!